{"id":"https://openalex.org/W2549889409","doi":"https://doi.org/10.1182/blood.v120.21.1758.1758","title":"Modeling JAK2V617F Heterozygous and Homozygous Mutations by Using Induced Pluripotent Stem Cells Derived From Myeloproliferative Neoplasms Patients","display_name":"Modeling JAK2V617F Heterozygous and Homozygous Mutations by Using Induced Pluripotent Stem Cells Derived From Myeloproliferative Neoplasms Patients","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2549889409","doi":"https://doi.org/10.1182/blood.v120.21.1758.1758","mag":"2549889409"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.1758.1758","doi":"https://doi.org/10.1182/blood.v120.21.1758.1758","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.1758.1758","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028844020","display_name":"Joseph Saliba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Joseph Saliba","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045031806","display_name":"Sofiane Hamidi","orcid":"https://orcid.org/0000-0002-1189-843X","observed_orcids":["https://orcid.org/0000-0002-1189-843X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sofiane Hamidi","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086105541","display_name":"Antonio Di Stefano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Antonio Di Stefano","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083462734","display_name":"Thierry Langlois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Thierry Langlois","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050461936","display_name":"Ga\u00eblle Lenglet","orcid":"https://orcid.org/0000-0003-0572-844X","observed_orcids":["https://orcid.org/0000-0003-0572-844X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Gae\u0308lle Lenglet","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061651965","display_name":"Lise Secardin","orcid":"https://orcid.org/0000-0002-5776-7531","observed_orcids":["https://orcid.org/0000-0002-5776-7531"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Lise Secardin","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010488274","display_name":"Anne H. M. Galy","orcid":"https://orcid.org/0000-0002-0153-4392","observed_orcids":["https://orcid.org/0000-0002-0153-4392"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Galy","raw_affiliation_strings":["Genethon, INSERM U951, Evry, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, INSERM U951, Evry, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056220279","display_name":"Paule Opolon","orcid":"https://orcid.org/0000-0002-9758-1408","observed_orcids":["https://orcid.org/0000-0002-9758-1408"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Paule Opolon","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108600793","display_name":"Najet Debili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Najet Debili","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009104683","display_name":"Hana Raslov\u00e1","orcid":"https://orcid.org/0000-0001-8846-5299","observed_orcids":["https://orcid.org/0000-0001-8846-5299"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Hana Raslova","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021249110","display_name":"Fran\u00e7oise Norol","orcid":"https://orcid.org/0000-0003-2490-3880","observed_orcids":["https://orcid.org/0000-0003-2490-3880"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Franc\u0327oise Norol","raw_affiliation_strings":["Laboratoire de The\u0301rapie Cellulaire, Ho\u0302pital Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de The\u0301rapie Cellulaire, Ho\u0302pital Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France","institution_ids":["https://openalex.org/I4210121705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000559973","display_name":"Isabelle Plo","orcid":"https://orcid.org/0000-0002-5915-6910","observed_orcids":["https://orcid.org/0000-0002-5915-6910"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Isabelle Plo","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081008172","display_name":"William Vainchenker","orcid":"https://orcid.org/0000-0003-4705-202X","observed_orcids":["https://orcid.org/0000-0003-4705-202X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"William Vainchenker","raw_affiliation_strings":["INSERM U1009, Institut Gustave Roussy, Villejuif, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1009, Institut Gustave Roussy, Villejuif, France,","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000559973","https://openalex.org/A5009104683","https://openalex.org/A5021249110","https://openalex.org/A5050461936","https://openalex.org/A5056220279","https://openalex.org/A5061651965","https://openalex.org/A5083462734","https://openalex.org/A5086105541","https://openalex.org/A5108600793"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802","https://openalex.org/I4210121705"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"120","issue":"21","first_page":"1758","last_page":"1758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9189000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9189000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":0.06599999964237213,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.8859999775886536},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9940000176429749},{"id":"https://openalex.org/keywords/induced-pluripotent-stem-cells","display_name":"induced pluripotent stem cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/disease-modeling","display_name":"disease modeling","score":0.9340000152587891},{"id":"https://openalex.org/keywords/erythroid-progenitors","display_name":"erythroid progenitor cells","score":0.8690000176429749},{"id":"https://openalex.org/keywords/megakaryocyte-progenitors","display_name":"megakaryocyte progenitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/erythropoietin-sensitivity","display_name":"erythropoietin sensitivity","score":0.875},{"id":"https://openalex.org/keywords/20q-deletion","display_name":"20q deletion","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cd34-cells","display_name":"CD34+ cells","score":0.753000020980835},{"id":"https://openalex.org/keywords/teratoma-formation","display_name":"teratoma formation","score":0.5070000290870667},{"id":"https://openalex.org/keywords/cytokine-responsiveness","display_name":"cytokine responsiveness","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.7895791530609131},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7515230178833008},{"id":"https://openalex.org/C2777933648","wikidata":"https://www.wikidata.org/wiki/Q21114866","display_name":"SOX2","level":4,"score":0.6837907433509827},{"id":"https://openalex.org/C2778265714","wikidata":"https://www.wikidata.org/wiki/Q18033993","display_name":"KLF4","level":5,"score":0.540840744972229},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47221189737319946},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.46880868077278137},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.45086437463760376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4454458951950073},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.44098618626594543},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.41289955377578735},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4125511944293976},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3142593204975128},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11918953061103821}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.1758.1758","doi":"https://doi.org/10.1182/blood.v120.21.1758.1758","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.1758.1758","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990398429","https://openalex.org/W6887981786","https://openalex.org/W2739179787","https://openalex.org/W1715696534","https://openalex.org/W4386792951","https://openalex.org/W2914652680","https://openalex.org/W3135028563","https://openalex.org/W6992893770","https://openalex.org/W6944311439","https://openalex.org/W6921197911"],"abstract_inverted_index":{"Abstract":[0,1],"1758":[2],"During":[3],"the":[4,117,120,132,138,160,166,201,236,251,279,285,309,321,327,340,356,363,394,402,406],"last":[5],"several":[6,64,333],"years,":[7],"iPS":[8,55,65,133,155,244,260,269,286,360],"cells":[9,31,72],"have":[10,44],"been":[11],"described":[12],"as":[13,233,287],"a":[14,74,78,84,182,193,271,288,298,317,398],"new":[15,127],"powerful":[16],"tool":[17,290],"for":[18,116,149,291],"disease":[19],"modeling":[20,49],"and":[21,83,103,124,141,147,174,222,283,336,344,349,374,400],"drug":[22],"screening.":[23],"It":[24],"became":[25],"possible":[26],"to":[27,106,200,220,225,235,263,354,379,392,404,418],"reprogram":[28],"adult":[29],"patients":[30,53,143,161],"into":[32],"specific":[33],"pluripotent":[34,93,98],"cell":[35,66,90,134],"lines":[36,67,91,135],"harboring":[37],"inherited":[38],"and/or":[39],"acquired":[40],"genetic":[41],"abnormalities.":[42,130],"We":[43],"focused":[45],"our":[46],"work":[47],"on":[48,339],"Jak2V617F":[50],"positive":[51],"MPN":[52,293,399],"in":[54,109,185,196,198,207,230,308,397,401],"cells.":[56,163],"By":[57],"retroviral":[58],"infection":[59],"(OCT4,":[60],"SOX2,":[61],"KLF4,":[62],"c-Myc),":[63],"were":[68,104,114,144,210,352],"generated":[69],"from":[70,137,159,241,250,257,267],"CD34+":[71,162],"of":[73,119,304,323,326,366,409,416],"healthy":[75],"donor":[76],"(control),":[77],"heterozygous":[79,140,146,243,259,373],"JAK2":[80,86,152,310,348],"V617F":[81,87],"patient":[82],"homozygous":[85,142,148,167,268,375],"patient.":[88],"All":[89,131],"expressed":[92],"surface":[94],"markers":[95],"(TRA1\u201381,":[96],"SSEA4),":[97],"genes":[99],"(NANOG,":[100],"OCT4,":[101],"SOX2)":[102],"capable":[105],"induce":[107],"teratomas":[108],"immunodeficient":[110],"mice.":[111],"Moreover,":[112],"they":[113],"silenced":[115],"expression":[118],"4":[121],"exogenous":[122],"transgenes":[123],"showed":[125,270,297,345],"no":[126,169],"clonal":[128,395],"karyotypic":[129],"derived":[136,315],"JAK2V617F":[139,188,242,258,292,367],"also":[145,389],"JAK2V617F.":[150],"No":[151,413],"wild":[153],"type":[154],"could":[156],"be":[157,390],"obtained":[158],"Interestingly":[164],"all":[165],"JAK2V617Fhad":[168],"20q":[170],"deletion":[171,180],"by":[172],"cytogenetic":[173],"CGH":[175],"analysis":[176],"demonstrating":[177],"that":[178,346],"this":[179,186],"was":[181,314],"secondary":[183],"event":[184],"MPN.":[187],"mutation":[189],"did":[190],"not":[191],"elicit":[192],"significant":[194],"increase":[195],"hematopoiesis":[197],"comparison":[199],"control":[202],"iPS.":[203],"However,":[204],"marked":[205,370],"differences":[206,371],"cytokine":[208,364],"sensitivity":[209],"found.":[211],"Homozygous":[212],"iPS-derived":[213],"erythroid":[214,228,239,342,357],"progenitors":[215,240,256],"had":[216,261],"spontaneous":[217,358],"growth,":[218],"hypersensitivity":[219,262,365],"EPO":[221],"gave":[223],"rise":[224],"slightly":[226],"larger":[227],"colonies":[229],"methylcellulose":[231],"assays":[232],"compared":[234],"control,":[237],"whereas":[238,265],"has":[245],"similar":[246],"Epo-response":[247],"than":[248],"those":[249,266],"control.":[252],"Interestingly,":[253],"Megakaryocytes":[254],"(MK)":[255],"TPO":[264,273],"complete":[272],"independence.":[274],"Those":[275],"cytokine-response":[276],"profiles":[277],"recapitulate":[278],"disease's":[280],"primary":[281],"features":[282],"validate":[284],"good":[289],"modeling.":[294],"MK":[295,328],"differentiation":[296],"maturation":[299],"defect":[300],"with":[301,316,369],"an":[302,385],"excess":[303],"immature":[305],"MKs":[306],"only":[307,347],"V617Fhomozygous":[311],"lines,":[312],"who":[313],"post-PV":[318],"myelofibrosis,":[319],"suggesting":[320],"existence":[322],"intrinsic":[324],"abnormalities":[325],"lineage.":[329],"Finally,":[330],"we":[331],"tested":[332],"JAK2,":[334],"PI3K":[335,350],"ERK":[337],"inhibitors":[338,351],"JAK2V617F-mediated":[341],"growth":[343],"able":[353],"block":[355],"growth.":[359],"technology":[361],"recapitulates":[362],"MPNs":[368],"between":[372],"mutations,":[376],"enabling":[377],"us":[378],"screen":[380],"various":[381],"pharmaceutical":[382],"inhibitors.":[383],"In":[384],"addition":[386],"it":[387],"can":[388],"used":[391],"study":[393,405],"hierarchy":[396],"future":[403],"synergistic":[407],"effects":[408],"different":[410],"mutations.":[411],"Disclosures:":[412],"relevant":[414],"conflicts":[415],"interest":[417],"declare.":[419]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-30T00:00:00"}